{"transactions":[{"id":702953,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-27T20:10:08.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":108000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":108000,"derivative":{"exercise_price":22.01,"expiration_date":"2036-07-22","underlying":"Common Stock","underlying_shares":108000},"source":{"system":"sec-edgar","filing":"0001997584-26-000006","document":"form4-07272026_040703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000006/form4-07272026_040703.xml","form_type":"4"}},{"id":702952,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-27T20:10:08.000Z","date":"2026-07-23","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of the Issuer's common stock (\"Common Stock\") underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":69805,"source":{"system":"sec-edgar","filing":"0001997584-26-000006","document":"form4-07272026_040703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000006/form4-07272026_040703.xml","form_type":"4"}},{"id":713575,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on October 16, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":290000,"derivative":{"exercise_price":8.73,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713574,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":16072,"price":23.44,"value":376727.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction report was $23.44, and the range of prices were between $23.26 and $23.67, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":15805,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713573,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":16214,"price":22.76,"value":369030.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction report was $22.76, and the range of prices were between $22.26 and $23.25, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":31877,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713572,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":22714,"price":21.95,"value":498572.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $21.95, and the range of prices were between $21.26 and $22.25, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":48091,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":713571,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-07T21:42:16.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":8.73,"value":480150.0,"ownership":{"direct":true},"balance_after":70805,"source":{"system":"sec-edgar","filing":"0001997584-26-000004","document":"form4-07072026_090711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000004/form4-07072026_090711.xml","form_type":"4"}},{"id":723933,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":false,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vested on October 16, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":345000,"derivative":{"exercise_price":8.73,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":723932,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":14420,"price":20.66,"value":297917.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction report was $20.66, and the range of prices were between $20.275 and $21.02, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":15805,"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":723931,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":40580,"price":19.56,"value":793744.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 26, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction report was $19.56, and the range of prices were between $19.27 and $20.255, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":30225,"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":723930,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-29T20:52:50.000Z","date":"2026-06-25","kind":"exercise","planned":true,"acquired":true,"shares":55000,"price":8.73,"value":480150.0,"ownership":{"direct":true},"balance_after":70805,"source":{"system":"sec-edgar","filing":"0001997584-26-000002","document":"form4-06292026_080646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000199758426000002/form4-06292026_080646.xml","form_type":"4"}},{"id":1078354,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-31T22:57:22.000Z","date":"2025-07-29","kind":"grant","planned":false,"acquired":true,"shares":242000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":242000,"derivative":{"exercise_price":10.6,"expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":242000},"source":{"system":"sec-edgar","filing":"0001415889-25-020786","document":"form4-07312025_100718.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588925020786/form4-07312025_100718.xml","form_type":"4"}},{"id":1352619,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-11-25T13:35:28.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":15805,"price":9.478,"value":149799.79,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The purchase price for the reported transactions was $9.478.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased."}],"balance_after":15805,"source":{"system":"sec-edgar","filing":"0001415889-24-027599","document":"form4-11252024_011125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924027599/form4-11252024_011125.xml","form_type":"4"}},{"id":1434784,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-08-13T21:40:48.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter."}],"balance_after":200000,"derivative":{"exercise_price":12.92,"expiration_date":"2034-08-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-24-021228","document":"form4-08132024_090844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000141588924021228/form4-08132024_090844.xml","form_type":"4"}},{"id":1753120,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":28532,"kind":"person","name":"Lechleider Robert","position":1,"cik":"0001997584","reported_name":"Lechleider Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-10-31T22:30:54.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on October 16, 2024, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":400000,"derivative":{"exercise_price":8.73,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-23-053982","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919123053982/doc4.xml","form_type":"4"}}]}